
CAS 177943-89-4
:4,7,10-tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl-D-phe-cys-tyr-D-trp-lys-thr-cys-thr-OH, (Disulfidbrücke) acetat
- Dota-(Tyr3)-Octreotate Acetate
- Dota-(Tyr3,Thr8)-Octreotide Acetate
- DOTA-[Tyr3]-Octreotate, DOTA-[Tyr3, Thr8]-Octreotide, DOTA-TATE
- N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraaza-cyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-trypto-phyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic(2-7) disulfide
DOTA-(Tyr³)-Octreotate
CAS:DOTA-conjugated somatostatin analog for labeling with radiometals such as gallium-67 or gallium-68, indium-111, and yttrium-90. DOTA-TATE is a useful tool in receptor-mediated tumor imaging and peptide receptor-targeted radionuclide therapy. CAS-Number (net): 177943-88-3.Formel:C65H90N14O19S2Reinheit:97.5%Farbe und Form:White PowderMolekulargewicht:1435.65DOTATATE acetate
CAS:DOTATATE acetate is a DOTA-binding peptide involved in the assessment of functional imaging of highly differentiated neuroendocrine tumors (NETs).Formel:C60H90N14O19S2xC2H4O2Reinheit:98.70%Farbe und Form:SolidDOTA-(Tyr3)-Octreotate acetate salt
CAS:Formel:C67H94N14O21S2Reinheit:98%Farbe und Form:SolidMolekulargewicht:1495.6745DOTA-(Tyr3)-Octreotate acetate salt
CAS:Kontrolliertes ProduktOctreotate is a radiopharmaceutical that is synthesized by reacting DOTA-Tyr3 with octreotide acetate. Octreotate, also known as dotatate, is used in nuclear medicine to treat neuroendocrine tumours. This drug has a high yield and can be reliably prepared using cassettes and computerised equipment to create germanium-68 labelled octreotate. The radionuclide emits positrons and gamma rays, which are used for imaging neuroendocrine tumours in the brain or other organs. Octreotate is a synthetic analogue of the natural hormone octreotide, which binds to receptors on the cell surface and prevents the release of hormones from cells. This may be due to its ability to inhibit protein synthesis by inhibiting rRNA synthesis.
Formel:C65H90N14O19S2Reinheit:Min. 95 Area-%Farbe und Form:White Slightly Yellow PowderMolekulargewicht:1,435.63 g/molDOTA-(Tyr3)-octreotate Acetate Salt
CAS:Kontrolliertes ProduktStability Hygroscopic
Applications DOTA-(Tyr3)-octreotate can be obtained through preparation of DOTA-containing peptides and radionucleotide complexes as antitumor agents for treating somatostatin postive tumor and metastasized tumors.
References Albert, R., et al.: Jpn. Kokai Tokkyo Koho, JP 08081498 A 19960326 (1996)Formel:C65H90N14O19S2·xCH3COOHFarbe und Form:NeatMolekulargewicht:1495.68






